NEW YORK — TNG Dx said on Tuesday that it has partnered with Premier Medical Laboratories to develop a rapid RNA extraction protocol for use with SARS-CoV-2 diagnostics.
TNG Dx, a New York City-based startup focused on SARS-CoV-2 test and technology distribution, said that it has collected over 500 paired saliva samples using anterior nasal sampling at the Harris Country testing site near Houston, Texas.